NEW YORK — October 10, 2022 — Berkery Noyes, an independent mid-market investment bank, today released its third quarter 2022 mergers and acquisitions trend report for the Healthcare/Pharma Information and Technology Industry.
The report analyzes M&A activity for the sector during third quarter 2022 and compares it with second quarter 2022. This market includes information, technology, and digital companies servicing the pharmaceutical, healthcare payer, and healthcare provider spaces.
Total transaction volume in third quarter 2022 increased by 14 percent over second quarter 2022. Total transaction value during this timeframe rose by 82 percent, from $5.1 billion to $9.3 billion.
Deal flow in the Healthcare IT segment improved 22 percent over second quarter 2022. M&A activity in the combined Pharma IT, Pharma Business Services, and Pharma Information segments increased 39 percent. One notable Pharma IT deal in third quarter 2022 was McKesson Corporation’s announced acquisition of Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company, for $600 million.
Deal volume in the Healthcare Business Services segment remained about constant relative to the second quarter. The overall industry’s largest transaction in the third quarter and year-to-date was CVS Health’s announced acquisition of Signify Health for $7.3 billion. Signify Health’s platform combines technology, analytics, and networks to create value-based payment programs. The Company’s network of physicians, nurse practitioners, and physician assistants utilize home-based visits to identify a patient’s clinical and social needs.
A copy of the HEALTHCARE/PHARMA INFORMATION AND TECHNOLOGY INDUSTRY M&A REPORT FOR THIRD QUARTER 2022 is available at the Berkery Noyes website.